28Mar 2018

IMMUNE THROMBOCYTOPENIA. EGYPTIAN EXPERIENCE WITH STUDY OF IL-17, TGFB, CYTOKINES IN CHRONIC AND PERSISTENT IMMUNE THROMBOCYTOPENIA PATIENTS.

  • Internal medicine Department -Cairo University.
  • Internal Medicine Department- Bani Sweif University.
  • clinical Pathology Department- Bani sweif Unsiversity.
Crossref Cited-by Linking logo

  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Background: Autoimmune diseases are characterized by various factors that contribute to a breakdown in self tolerance. In this study we review the demographic features of 150 immune thrombocytopenic Egyptian patients and for cases who were chronic and persistent with negative both autoimmune screen and virology for hepatitis B and C, we measured IL-17 and TGF-β by ELISA. Results: Our results revealed Chronic and persistent cases who fulfilled the criteria for cytokine assay were 45 cases with a mean (? SD) age of 31.60 ? 8.78 years. Thirty two patients were presented by skin manifestations (71.1%).Eight patients presented with mucous bleeding (17.8%) and five patients presented by combined skin and mucous membrane bleeding (11.1%). Comparison between the cases studied and control groups revealed statistically significant lower platelet count in cases rather than the control. While the two measured cytokines were statistically significant higher in cases rather than the control. Correlation between platelet count and the level of cytokines was statistically insignificant. All cases were under treatment by low dose corticosteroid in addition to another immunesuppression medication. Conclusion: the higher expression of Treg cytokines (IL-17 and TGF-B) may be explained by effect of immune suppression use or up regulation of their receptors on Treg cells which have resistance to their activity.

  1. Consolini R, Legitimo A, Caparello MC. The Centenary of Immune Thrombocytopenia - Part 1: Revising Nomenclature and Pathogenesis. Front Pediatr 2016; 4: 102.
  2. Yang Y, Xuan M, Zhang X, et al. Decreased IL-35 levels in patients with immune thrombocytopenia.Human Immunology 2014; 75: 909?13.
  3. Panitsas FP, Theodoropoulou M, Kouraklis A, Karakantza M, et al. Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response. Blood 2004; 103:2645?7.
  4. Yu J, Heck S, Patel V, Levan J, Yu Y, Bussel JB, et al. Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura. Blood 2008; 112(4):1325?8.
  5. Zhao C, Li X, Zhang F, et al. Increased cytotoxic T-lymphocyte-mediated cytotoxicity predominant in patients with idiopathic thrombocytopenic purpura without platelet autoantibodies. Haematologica 2008; 93:1428?30.
  6. Zhan Y, Hua F, Ji L, et al. Polymorphisms of the IL-23R gene are associated with primary immune thrombocytopenia but not with the clinical outcome of pulsed high-dose dexamethasone therapy. Ann Hematol 2013; 92:1057?62.
  7. Ma D, Zhu X, Zhao P, Zhao C, Li X, Zhu Y, Li L, Sun J, Peng J, Ji C, Hou M. Profile of Th17 cytokines (IL-17, TGF-beta, IL-6) and Th1 cytokine (IFN-gamma) in patients with immune thrombocytopenic purpura. Ann Hematol. 2008 Nov; 87(11):899-904.
  8. Yu S, Liu C, Li L, Tian T, Wang M, Hu Y, Yuan C, Zhang L, Ji C, Ma D. Lab Invest. 2015 Feb; 95(2):157-67. Inactivation of Notch signaling on Th17/Treg imbalances.
  9. Wan YY1, Flavell RA. TGF-beta and regulatory T cell in immunity and autoimmunity. See comment in PubMed Commons below J Clin Immunol. 2008 Nov;28(6):647-59.
  10. YeX, ZhangL,WangH,ChenY,ZhangW, ZhuR, et al.The Role of IL-23/Th17 Pathway in Patients with Primary Immune Thrombocytopenia. 2015. PLoSONE10(1):e0117704.doi:10.1371/journal. pone.0117704.
  11. Li W1, Wang X, Li J, Liu M, Feng J. A study of immunocyte subsets and serum cytokine profiles before and after immunal suppression treatment in patients with immune thrombocytopenia. Zhonghua Nei Ke Za Zhi. 2016 Feb;55(2):111-5. doi: 10.3760/cma.j.issn.0578-1426.2016.02.009.
  12. Huang WY1, Sun QH2, Chen YP Expression and Significance of CD4+ CD25+ CDl27low Regulatory T Cells, TGF-β and Notch1 mRNA in Patients with Idiopathic Thrombocytopenic Purpura .Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2015 Dec;23(6):1652-6. doi: 10.7534/j.issn.1009-2137.2015.06.023.
  13. Perera M1, Garrido T. Advances in the pathophysiology of primary immune thrombocytopenia. 2017 Jan;22(1):41-53. Epub 2016 Sep 27.

[Noha M. El Husseiny, Amira El Sobky, Ahmed Khalaf, Heba Hamdy, Sherin El Husseiny and Ashraf Genina. (2018); IMMUNE THROMBOCYTOPENIA. EGYPTIAN EXPERIENCE WITH STUDY OF IL-17, TGFB, CYTOKINES IN CHRONIC AND PERSISTENT IMMUNE THROMBOCYTOPENIA PATIENTS. Int. J. of Adv. Res. 6 (Mar). 1087-1090] (ISSN 2320-5407). www.journalijar.com

ahmed khallaf

DOI:

Article DOI: 10.21474/IJAR01/6770      
DOI URL: https://dx.doi.org/10.21474/IJAR01/6770

Download Full Paper

Download PDF No. of Downloads: 9 | No. of Views: 106